Skip to main content
Pulike Biological Engineering,Inc. logo

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 ISIN · CNE1000025N0 Shanghai Stock Exchange Manufacturing
Filings indexed 1,080 across all filing types
Latest filing 2020-02-26 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

http://en.pulike.com.cn/

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
第四届监事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the resolution of the first meeting of the fourth Supervisory Board of the company, including the election of the chairman of the Supervisory Board. It contains details about the meeting date, attendance, and voting results, as well as a brief biography of the elected chairman. There is no financial data, audit information, or report content. This fits the category of Board/Management Information (MANG), as it relates to changes in company governance personnel.
2020-02-26 Chinese
关于选举职工监事的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election of an employee supervisor (职工监事) for the company's supervisory board. It includes a statement of responsibility from the supervisory board and a brief personal resume of the elected individual. There is no financial data, no mention of financial results, no regulatory certifications, or report publications. The content is about board/management information specifically related to the supervisory board election. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is not a report or announcement of a report publication, so it is not RPA or RNS.
2020-02-26 Chinese
关于收到政府补助的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company about receiving government subsidy funds. It includes details about the subsidy amount, the date received, and the accounting treatment of the subsidy. There is no financial statement or comprehensive financial data presented. The document is brief (665 characters) and serves as a notification rather than a full report. It does not fit categories like Annual Report, Interim Report, or Earnings Release. It is an announcement related to financing but not a capital raising or financing update. The best fit is a Regulatory Filing (RNS) as it is a general regulatory announcement about government subsidy receipt.
2020-02-20 Chinese
股东集中竞价减持股份计划公告
Major Shareholding Notification Classification · 100% confidence The document is a formal announcement from a company regarding a shareholder's plan to reduce their holdings through a concentrated bidding process. It details the shareholder's identity, the number of shares to be reduced, the timeframe, and the reasons for the reduction. The document includes tables showing shareholding percentages and past reduction activities. There is no financial statement, earnings data, or management discussion. The content focuses on shareholding changes and reduction plans by a significant shareholder. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels.
2020-02-19 Chinese
2020年第一次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as materials for the "2020 First Extraordinary General Meeting of Shareholders" of 普莱柯生物工程股份有限公司. It includes detailed meeting instructions, agenda, and multiple proposals for shareholder approval, such as amendments to the remuneration system for directors and senior management, and the election of new board members and supervisors. The content is focused on the organization and conduct of a shareholders' meeting, including voting procedures and candidate biographies. There are no financial statements or earnings data, nor is this a transcript of a call or a report publication announcement. The document is clearly the meeting materials for a shareholders' meeting, specifically an Extraordinary General Meeting (EGM). According to the filing definitions, presentations and materials shared during the Annual General Meeting (AGM) or Extraordinary General Meeting fall under AGM Information (AGM-R). Therefore, this document is best classified as AGM Information (AGM-R).
2020-02-14 Chinese
关于获得新兽药注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of a new veterinary drug registration certificate. It details the product information, development background, market context, and regulatory steps remaining before the product can be marketed. There are no financial statements, earnings data, or management discussion of financial results. The document is an official announcement of a regulatory approval event rather than a financial report or management presentation. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is a regulatory announcement about a new product approval, which aligns best with the Regulatory Filings (RNS) category as a general regulatory announcement that does not fit other specific categories.
2020-02-13 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.